Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget

Simple item page
dc.coverageDOI: 10.4253/wjge.v14.i2.85
dc.creatorNúñez, F Paulina
dc.creatorQuera, Rodrigo
dc.creatorRubin, David T
dc.date2022
dc.date.accessioned05-01-2026 18:17
dc.date.available05-01-2026 18:17
dc.descriptionInflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic immune-mediated inflammatory disease that primarily affects the gastrointestinal tract and is characterized by periods of activity and remission. The inflammatory activity of the disease involving the colon and rectum increases the risk of colorectal cancer (CRC) over the years. Although prevention strategies are evolving, regular surveillance for early detection of neoplasia as a secondary prevention strategy is paramount in the care of IBD patients. In this review article, we discuss the current evidence of the risks of developing CRC and evaluate the best available strategies for screening and surveillance, as well as future opportunities for cancer prevention.spa
dc.identifierhttps://investigadores.uandes.cl/en/publications/2369aaa2-3508-4379-a575-7f8085cb77bc
dc.languagespa
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourcevol.14 (2022) nr.2 p.85-95
dc.subjectODS 3: Salud y bienestar
dc.titleEndoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forgetspa
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
Pure-CRIS